Evidence map›Paper›PMID 37230432›Full record

ReviewInternational journal of radiation oncology, biology, physics2023

Gender-Affirming Surgery and Cancer: Considerations for Radiation Oncologists for Pelvic Radiation in Transfeminine Patients.

Alicia C Smart, Kevin X Liu, Jason D Domogauer, Carlos Rodriguez-Russo, Brianna Jones, Daniel R Dickstein, Joseph D Mancias, Ron Y Shiloh, Anton Wintner, Anthony L Zietman and 3 more

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Alicia C SmartDepartment of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: acsmart@partners.org.
Kevin X LiuDepartment of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Jason D DomogauerDepartment of Radiation Oncology, New York University Langone Health, New York University, New York, New York.
Carlos Rodriguez-RussoDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Brianna JonesDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Daniel R DicksteinDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Joseph D ManciasDepartment of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
Ron Y ShilohDepartment of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
Anton WintnerDepartment of Urology, Massachusetts General Hospital, Boston, Massachusetts.
Anthony L ZietmanDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Deborah C MarshallDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
M Aiven DyerDepartment of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
Andrea L RussoDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Brigham and Women's Hospital · USIcahn School of Medicine at Mount Sinai · USMassachusetts General Hospital · USNYU Langone Health · US

Funding

Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center CohortDP5OD031876 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARSHALL, DEBORAH CATHERINE · 2021 to 2025
$2.1M
NIH HHS DP5 OD031876
6 · The paper itself

Abstract

Access to gender-affirming surgery is increasing for many transgender and nonbinary people in the United States, and radiation oncologists must be equipped to care for patients who have undergone such surgery in the region of their planned radiation treatment field. There are no guidelines for radiation treatment planning after gender-affirming surgery, and most oncologists do not receive training in the unique needs of transgender people with cancer. We review common gender-affirming genitopelvic surgeries for transfeminine people, including vaginoplasty, labiaplasty, and orchiectomy, and summarize the existing literature on the treatment of cancers of the neovagina, anus, rectum, prostate, and bladder in these patients. We also describe our systematic treatment approach and rationale for pelvic radiation treatment planning.

Indexed as

Gender-Affirming SurgeryNeoplasmsTransgender PersonsAnal CanalFemaleHumansMaleRadiation OncologistsVagina

Identifiers

PMID37230432
PMCPMC10527783
OpenAlexW4377690910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.